* To be consumed as directed by physician.
Silorap is a highly selective α1A-adrenergic receptor antagonist, primarily used in the treatment of Lower Urinary Tract Symptoms (LUTS) associated with Benign Prostatic Hyperplasia (BPH).
Copyright ©2025 All Rights Reserved by Hetero Healthcare Limited.